-- EXCLUSIVE-J&J hires Goldman to explore sale of Splenda - sources 
-- 
-- Wed Dec 03, 2014 09:48AM EST
-- None



NEW YORK/LONDON, Dec 3 (Reuters) - Johnson & Johnson <JNJ.N>, the U.S.-based healthcare company, has hired Goldman Sachs <GS.N> to explore a sale of its artificial sweetener brand Splenda, sources familiar with the matter told Reuters.

The process is still at an early stage, with prospective buyers currently signing non disclosure agreements, one of the sources said, speaking on condition of anonymity because the matter is private.  J&J declined to comment. Goldman Sachs was not immediately available.